Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy.
Ivaska
Kaisa K
KK
Institute of Biomedicine, Department of Anatomy, University of Turku, Finland.
Pettersson
Kim
K
Nenonen
Arja
A
Uusi-Rasi
Kirsti
K
Heinonen
Ari
A
Kannus
Pekka
P
Väänänen
H Kalervo
HK
D019386:Alendronate / Q000627:therapeutic use*; D015415:Biomarkers; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D007118:Immunoassay; D008875:Middle Aged; D015675:Osteocalcin / Q000652:urine*; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control / Q000652:urine; D013997:Time Factors
D015415:Biomarkers; D015675:Osteocalcin; D019386:Alendronate